Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis

Post-Transplant Outcomes in High-Risk Compared with Non–High-Risk Multiple Myeloma: A CIBMTR Analysis

(2016) Emma C. Scott et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

(2016) P. Sonneveld et al.   BLOOD

2016 US lymphoid malignancy statistics by World Health Organization subtypes

(2016) Lauren R. Teras et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Trends in overall survival and costs of multiple myeloma, 2000–2014

(2016) R Fonseca et al.   LEUKEMIA

Comparison of SEER Treatment Data With Medicare Claims

(2016) Anne-Michelle Noone et al.   MEDICAL CARE

Nuances in the Management of Older People With Multiple Myeloma

(2016) Charlotte Pawlyn et al.   Current Hematologic Malignancy Reports

Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma

(2015) Mark A. Fiala et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma

(2015) Luciano J. Costa et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

How I treat high-risk myeloma

(2015) S. Lonial et al.   BLOOD

Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis

(2015) Sikander Ailawadhi et al.   CANCER

Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents

(2014) Mohammed Al-Hamadani et al.   AMERICAN JOURNAL OF HEMATOLOGY

Transplants for the elderly in myeloma

(2013) G. J. Morgan   BLOOD

Multiple Myeloma Treatment Transformed: A Population-Based Study of Changes in Initial Management Approaches in the United States

(2013) Joan L. Warren et al.   JOURNAL OF CLINICAL ONCOLOGY

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

(2013) S K Kumar et al.   LEUKEMIA

Changes in survival by ethnicity of patients with cancer between 1992–1996 and 2002–2006: is the discrepancy decreasing?

(2012) D. Pulte et al.   ANNALS OF ONCOLOGY

Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups

(2012) Sikander Ailawadhi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

(2010) P. G. Richardson et al.   BLOOD

Racial disparities in incidence and outcome in multiple myeloma: a population-based study

(2010) A. J. Waxman et al.   BLOOD

Access to hematopoietic stem cell transplantation

(2010) Thomas V. Joshua et al.   CANCER

Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology Group

(2009) Kathy S. Albain et al.   JNCI-Journal of the National Cancer Institute

Pathogenesis and treatment of renal failure in multiple myeloma

(2008) M A Dimopoulos et al.   LEUKEMIA